MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Correlation of Neural Sensing with the Volume of Neural Activation within the Desired Patient-Specific Anatomical Target in Deep Brain Stimulation for Parkinson’s Disease

    M. Case, C. Zarns, A. Holt-Becker, R. Raike, E. Radcliffe, J. Thompson, D. Kern (Minneapolis, USA)

    Objective: Investigate the correlation between power in local field potential (LFP) beta band sensed from the subthalamic nucleus (STN) and the volume of neural activation…
  • 2024 International Congress

    Evaluation of theta burst transcranial ultrasound stimulation on motor cortex in Parkinson’s denovo patients.

    T. Grippe, Y. Shamli-Oghli, G. Darmani, Y. Lin, T. Arora, C. Sarica, N. Raies, JF. Nankoo, F. Cardoso, R. Chen (Toronto, Canada)

    Objective: Evaluate the neurophysiological and clinical effects of low-intensity transcranial ultrasound stimulation (TUS) of motor cortex (M1) in patients with Parkinson’s disease (PD) in different…
  • 2024 International Congress

    Lower Incidence of Parkinson’s Disease in Patients with Metabolic Syndrome or any of its Components: A Longitudinal Study

    R. Djaldetti, H. Avisar, U. Greenbaum, B. Lerner (Petah Tiqva, Israel)

    Objective: To examine the association between incident Parkinson’s disease (PD) and metabolic syndrome (MetS)  in a retrospective population study for an extensive period before diagnosis.…
  • 2024 International Congress

    Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

    S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)

    Objective: To define the profile of different cell signaling molecules in the blood of patients with Parkinson’s Disease (PD) compared to controls. Background: PD is…
  • 2024 International Congress

    Can Square Wave Jerks Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease? A Scoping Review

    Y. Xu, N. Bellacicco, E. Feinstein (Newark, USA)

    Objective: To review the available literature regarding the presence and properties of square wave jerks (SWJs) in Progressive Supranuclear Palsy (PSP) and Parkinson’s Disease (PD).…
  • 2024 International Congress

    Apraxia of eyelid opening in patients with movement disorders

    H. Conn, A. Lenka, J. Jankovic (Houston, USA)

    Objective: To determine the prevalence of apraxia of eyelid opening (AOELO) in patients with movement disorders evaluated at the Parkinson’s Disease Center and Movement Disorders…
  • 2024 International Congress

    Boosting Parkinson’s Disease Diagnosis: How Training Ethiopian Healthcare Workers and Enhancing Community Level Awareness Led to a Surge in Case Identification

    MRS. Yinesu (Addis Ababa, Ethiopia)

    Objective: The study assessed the effectiveness of a capacity development training program in improving the diagnosis of Parkinson's Disease (PD) by healthcare professionals Background: Parkinson's…
  • 2024 International Congress

    Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

    Objective: To discern preferences for education and community connection among people affected by progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA).…
  • 2024 International Congress

    GAD-Positive Versus GAD-Negative Stiff Person Syndrome: A Retrospective Study

    W. Khan, M. Hamed, H. Ooi, H. Sarva, M. Salgado, D. Victor (Doha, Qatar)

    Objective: Delineate demographic and clinical differences between GAD-65-antibody positive (seropositive) and negative (seronegative) SPS. Background: Elevated Glutamic Acid Decarboxylase 65 antibody (GAD-65 Ab) titers are…
  • 2024 International Congress

    Dandy-Walker syndrome. A case study.

    GM. Mussagaliyeva (Almaty, Kazakhstan)

    Objective: Present a case study with rare congenital disease for further сreating a database and developing algorithms for the management of such cases in the…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley